Abingdon Health is developing the next generation of multiplexed rapid diagnostics technology to meet the market need for a simple to use, rapid, cost effective, portable systems.
Our rapid testing system patented technology integrates low-cost Organic Light Emitting diodes (OLEDs) and Organic Photodetectors (OPDs) with immunoassay lateral flow chemistry to allow the quantitative measurement of a range of multiplexed assay panels.
The benefits of the technology platform include the following:
This technology can be applied to the medical, veterinary, food safety, plant testing, and homeland security sectors.
Abingdon Health is developing the multiplexed point-of-care biosensor in partnership with Cambridge Display Technology Limited (“CDT”), a Sumitomo Chemical Group Company.
In addition, the collaboration has been established to prove the feasibility of the device in order to accommodate diagnostic market requirements.
For more information about our multiplexed biosensor please call +44 (0) 1904 406080 or email firstname.lastname@example.org.
© Abingdon Health 2017